Group 1 - Janus International Group, Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15 per share, but down from $0.21 per share a year ago, representing an earnings surprise of +33.33% [1] - The company posted revenues of $228.1 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 7.04%, although this is a decrease from year-ago revenues of $248.4 million [2] - Janus International Group shares have increased approximately 18.1% since the beginning of the year, outperforming the S&P 500's gain of 7.9% [3] Group 2 - The company's earnings outlook is crucial for investors, including current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The estimate revisions trend for Janus International Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] - The current consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $226.6 million, and for the current fiscal year, it is $0.65 on revenues of $881 million [7] Group 3 - The outlook for the Building Products - Miscellaneous industry, where Janus International Group operates, is currently in the bottom 37% of over 250 Zacks industries, which may impact the stock's performance [8]

Summary of Acadia Pharmaceuticals Core Viewpoint Acadia Pharmaceuticals reported better-than-expected quarterly earnings and revenue, indicating strong performance in the medical-biomedical and genetics industry, despite mixed estimate revisions for future earnings. Financial Performance - Acadia reported quarterly earnings of $0.16 per share, exceeding the Zacks Consensus Estimate of $0.14 per share, but down from $0.20 per share a year ago, representing an earnings surprise of +14.29% [1] - The company posted revenues of $264.57 million for the quarter, surpassing the Zacks Consensus Estimate by 1.87% and up from $241.96 million year-over-year [2] - Over the last four quarters, Acadia has surpassed consensus EPS estimates three times and topped revenue estimates four times [2] Stock Performance - Acadia shares have increased approximately 28.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.1% [3] - The current Zacks Rank for Acadia is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $271.4 million, and for the current fiscal year, it is $0.49 on revenues of $1.06 billion [7] - The outlook for the industry, particularly the Medical - Biomedical and Genetics sector, is currently in the bottom 42% of Zacks industries, which may impact stock performance [8]

Financial Performance - Ivanhoe Electric reported a quarterly loss of $0.16 per share, which aligns with the Zacks Consensus Estimate, an improvement from a loss of $0.39 per share a year ago [1] - The company posted revenues of $1.07 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 44.32%, compared to revenues of $0.54 million in the same quarter last year [2] - The current consensus EPS estimate for the upcoming quarter is -$0.22 on revenues of $0.74 million, and for the current fiscal year, it is -$0.78 on revenues of $2.93 million [7] Stock Performance - Ivanhoe Electric shares have increased approximately 30.6% since the beginning of the year, outperforming the S&P 500's gain of 7.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Industry Outlook - The Mining - Miscellaneous industry, to which Ivanhoe Electric belongs, is currently ranked in the bottom 36% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Ivanhoe Electric's stock performance [5]

Group 1: Earnings Performance - Suncor Energy reported quarterly earnings of $0.51 per share, exceeding the Zacks Consensus Estimate of $0.50 per share, but down from $0.93 per share a year ago, representing an earnings surprise of +2.00% [1] - The company posted revenues of $8.6 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 11.28%, compared to year-ago revenues of $9.53 billion [2] - Over the last four quarters, Suncor Energy has consistently surpassed consensus EPS estimates [2] Group 2: Stock Performance and Outlook - Suncor Energy shares have increased approximately 9.3% since the beginning of the year, outperforming the S&P 500's gain of 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.65 on revenues of $8.16 billion, and for the current fiscal year, it is $2.84 on revenues of $32.81 billion [7] - The estimate revisions trend for Suncor Energy was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Group 3: Industry Context - The Oil and Gas - Integrated - Canadian industry, to which Suncor Energy belongs, is currently ranked in the top 41% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - The Beachbody Company reported a quarterly loss of $0.57 per share, which was better than the Zacks Consensus Estimate of a loss of $0.93, and an improvement from a loss of $1.59 per share a year ago, resulting in an earnings surprise of +38.71% [1] - The company achieved revenues of $63.94 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 14.59%, although this represents a decline from year-ago revenues of $110.18 million [2] - The Beachbody Company has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has underperformed, losing about 36.6% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is -$1.19 on revenues of $48.5 million, and for the current fiscal year, it is -$4.40 on revenues of $221.8 million [7] 分组3 - The Zacks Industry Rank indicates that the Consumer Services - Miscellaneous sector is in the top 41% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - The estimate revisions trend for The Beachbody Company was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Group 1: Earnings Performance - Devon Energy reported quarterly earnings of $0.84 per share, exceeding the Zacks Consensus Estimate of $0.83 per share, but down from $1.41 per share a year ago, representing an earnings surprise of +1.20% [1] - The company posted revenues of $4.28 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.75%, compared to year-ago revenues of $3.92 billion [2] - Over the last four quarters, Devon Energy has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - Devon Energy shares have declined approximately 2.4% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $1.00 on revenues of $4.21 billion, and for the current fiscal year, it is $4.14 on revenues of $16.93 billion [7] Group 3: Industry Context - The Zacks Industry Rank for Oil and Gas - Exploration and Production - United States is currently in the bottom 31% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Devon Energy was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]

Company Performance - AC Immune reported a quarterly loss of $0.25 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.20, marking an earnings surprise of -25.00% [1] - The company posted revenues of $1.58 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 57.3%, compared to revenues of $0.76 million a year ago [2] - Over the last four quarters, AC Immune has surpassed consensus EPS estimates three times but has topped consensus revenue estimates only once [2] Stock Outlook - AC Immune shares have declined approximately 18.7% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is -$0.24 on revenues of $1.14 million, and for the current fiscal year, it is -$0.93 on revenues of $6.04 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which AC Immune belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact AC Immune's stock performance [5][6]

Zoetis (ZTS) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.56 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of +8.64%. A quarter ago, it was expected that this animal health company would post earnings of $1.4 per share when it actually produced earnings of $1.48, delivering a surprise of +5.71%. What's Next for Zoetis? While Zoeti ...

Core Viewpoint - Ares Commercial Real Estate (ACRE) reported a significant quarterly loss of $0.51 per share, which was much worse than the Zacks Consensus Estimate of a loss of $0.02, indicating a substantial earnings surprise of -2,450.00% [1] Financial Performance - The company posted revenues of $23.12 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 16.06% and down from $40.85 million in the same quarter last year [2] - Over the last four quarters, ACRE has only surpassed consensus EPS estimates once [2] Stock Performance - ACRE shares have declined approximately 23.3% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] Future Outlook - The company's earnings outlook will be crucial for determining the stock's immediate price movement, with current consensus EPS estimates indicating breakeven on $27.11 million in revenues for the upcoming quarter and $0.06 on $107.43 million in revenues for the current fiscal year [4][7] - The estimate revisions trend for ACRE was favorable prior to the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] Industry Context - The REIT and Equity Trust industry, to which ACRE belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable environment for stocks in this sector [8]

Group 1: Earnings Performance - IAC reported quarterly earnings of $2.57 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.3 per share, representing an earnings surprise of +956.67% [1] - The company posted revenues of $586.93 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.53%, and down from $949.53 million year-over-year [2] Group 2: Market Performance - IAC shares have declined approximately 10% since the beginning of the year, contrasting with the S&P 500's gain of 6.1% [3] - The current Zacks Rank for IAC is 4 (Sell), indicating expectations of underperformance in the near future [6] Group 3: Future Outlook - The consensus EPS estimate for the upcoming quarter is breakeven on revenues of $615.9 million, while for the current fiscal year, it is -$2.47 on revenues of $2.48 billion [7] - The outlook for the industry, specifically the Diversified Operations sector, is currently in the top 21% of Zacks industries, suggesting potential positive impacts on stock performance [8]